Product How it works Pricing Blog FAQ About Contact
Español English
EspañolEnglish
Log inCreate free account
Becton Dickinson

Becton Dickinson (NYSE: BDX) insider transactions

In the twelve months to 10 November 2026, executives and directors of Becton Dickinson reported 22 open-market sales of 18,729 shares ($3.4m) and 0 open-market purchases, by 5 people, according to the Form 4 filings they submitted to the SEC.

Latest transactions

The 20 most recent transactions in Becton Dickinson shares reported on Form 4
DateInsiderRoleTransactionSharesPriceHeld afterFiling
5 November 2026Polen Thomas E JrChairman, CEO and PresidentOption exercise, 10b5-1 plan+20,239$178.94130,402Form 4
5 November 2026Polen Thomas E JrChairman, CEO and PresidentReturned to the company, 10b5-1 plan−17,246$210.00113,156Form 4
5 November 2026Polen Thomas E JrChairman, CEO and PresidentOpen-market sale, 10b5-1 plan−2,993$210.00110,163Form 4
26 October 2026Feld MichaelEVP, Chief Revenue OfficerOpen-market sale, 10b5-1 plan−76$198.1319,568Form 4
28 September 2026Feld MichaelEVP, Chief Revenue OfficerOpen-market sale, 10b5-1 plan−76$183.7019,644Form 4
2 September 2026Roque VitorEVP & Chief Financial OfficerShares withheld for tax−190—8,041Form 4
26 August 2026Feld MichaelEVP, Chief Revenue OfficerOpen-market sale, 10b5-1 plan−165$188.4919,720Form 4
20 August 2026Feld MichaelEVP, Chief Revenue OfficerShares withheld for tax−1,049—19,885Form 4
13 August 2026Polen Thomas E JrChairman, CEO and PresidentOption exercise, 10b5-1 plan+43,278$167.25153,441Form 4
13 August 2026Polen Thomas E JrChairman, CEO and PresidentReturned to the company, 10b5-1 plan−39,126$185.00114,315Form 4
13 August 2026Polen Thomas E JrChairman, CEO and PresidentOpen-market sale, 10b5-1 plan−4,152$185.00110,163Form 4
11 August 2026Goette RolandEVP and President, EMEAOpen-market sale−2,438$180.8414,856Form 4
27 July 2026Feld MichaelEVP, Chief Revenue OfficerOpen-market sale, 10b5-1 plan−75$157.1320,934Form 4
2 July 2026Muhsin BilalEVP & President Connected CareShares withheld for tax−1,935—41,359Form 4
1 July 2026Muhsin BilalEVP & President Connected CareGrant or award+14,342—43,294Form 4
26 June 2026Feld MichaelEVP, Chief Revenue OfficerOpen-market sale, 10b5-1 plan−75$152.8021,009Form 4
24 June 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmOpen-market sale, 10b5-1 plan−1,100$145.6613,172Form 4
10 June 2026Garrison Michael DavidEVP & Pres Med.Essntl&BioPharmOpen-market sale, 10b5-1 plan−1,100$151.4814,272Form 4
1 June 2026Polen Thomas E JrChairman, CEO and PresidentOption exercise, 10b5-1 plan+20,209$126.16125,680Form 4
1 June 2026Polen Thomas E JrChairman, CEO and PresidentReturned to the company, 10b5-1 plan−17,445$146.15108,235Form 4

Names appear as in the filing, surname first. A dash in the price column means the filing reports none, as in grants and gifts.

How to read the table

Only open-market purchases and sales are trades the insider chose to make at the market price, and they are the ones counted in the summary above. Grants, option exercises and shares withheld for tax come from pay plans. A sale marked as a 10b5-1 plan was scheduled in advance under a written plan.

Where each row comes from

From the Form 4 that each executive, director or large shareholder must file with the SEC within two business days of a transaction, read up to 10 November 2026. Each row links to its filing on EDGAR. Only transactions in shares are listed, not derivatives, and amended filings are left out. The accounts of the company are on the Becton Dickinson page; the method, in data sources.

Information prepared from the Form 4 filings submitted to the SEC, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.